✦ LIBER ✦

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20mg Compared with Rosuvastatin 10mg in High-Risk Patients with and Without Type 2 Diabetes Mellitus (T2DM)

✍ Scribed by Philippe Brudi; Helena Vaverkova; Michel Farnier; Maurizio Averna; Margus Viigimaa; Qian Dong; Arvind Shah; Amy O. Johnson-Levonas; Luc Missault

Book ID: 119287739
Publisher: Elsevier
Year: 2009
Tongue: English
Weight: 96 KB
Volume: 3
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2009.04.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid-Altering Efficacy of Ezetimibe/Sim

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20mg Compared with Rosuvastatin 10mg in High-Risk Patients with and Without Type 2 Diabetes Mellitus

✍ Jennifer Rotonda 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 96 KB

Lipid-Altering Efficacy of Ezetimibe/Sim

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy

✍ Helena Vaverkova; Michel Farnier; Maurizio Averna; Luc Missault; Margus Viigimaa 📂 Article 📅 2010 🏛 Hindawi Limited 🌐 English ⚖ 895 KB

Efficacy of ezetimibe/simvastatin 10/20

Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus

✍ C. Constance; S. Westphal; N. Chung; M. Lund; C. McCrary Sisk; A. O. Johnson-Lev 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Efficacy of Ezetimibe/Simvastatin 10/20

Efficacy of Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High-Risk Patients With or Without Obesity

✍ Luc Missault; Maurizio Averna; Michel Farnier; Helena Vaverkova; Margus Viigimaa 📂 Article 📅 2011 🏛 Springer Healthcare Communications ⚖ 677 KB

Lipid-altering efficacy of ezetimibe/sim

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy – The IN-CROSS study

✍ M. Farnier; M. Averna; L. Missault; H. Vaverkova; M. Viigimaa; R. Massaad; K. Va 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Lipid-altering efficacy of switching fro

Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease

✍ V. Barrios; N. Amabile; F. Paganelli; J-W Chen; C. Allen; A. O. Johnson-Levonas; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB